Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hereditary Spastic Paraplegia Type 5”

3 trials

Showing 3 of 3 results

Not applicableLooking for participantsNCT06092346
What this trial is testing

A Natural History Study Seeks to Understand the Clinical, Genomic, Pharmacological, Laboratory, and Dietary Determinates of Pyrimidine and Purine Metabolism Disorders

Who this might be right for
AMPD3, OMIM*102772, AMP Deaminase DeficiencyAK1, OMIM *103000, Adenylate Kinase DeficiencyAMPD1, OMIM *102770, Myopathy Due to Myoadenylate Deaminase Deficiency+25 more
National Human Genome Research Institute (NHGRI) 999
Not applicableStudy completedNCT05174403
What this trial is testing

Imaging Biomarkers in Spastic Paraplegia Type 5

Who this might be right for
Spastic Paraplegia Type 5A, Recessive
Assistance Publique - Hôpitaux de Paris 10
Testing effectiveness (Phase 2)UnknownNCT04101643
What this trial is testing

PCSK9 Inhibitor Treatment for Patients With SPG5

Who this might be right for
Hereditary Spastic Paraplegia Type 5
First Affiliated Hospital of Fujian Medical University 30

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation